The article suggests that CCL2-dependent macrophage infiltration and M2-like polarization, along with the upregulation of PD-L1 in tumor cells, represent the potential mechanisms by which SLFN11 deficiency facilitates immune evasion in liver cancer. This evidence concerns the gene CCL2 and liver cancer.